Results 221 to 230 of about 25,099 (263)
Some of the next articles are maybe not open access.
Ten years of cholinesterase inhibitors
International Journal of Geriatric Psychiatry, 2009AbstractIn this editorial we have summarised ten years of evidence relating to the use of cholinesterase inhibitors in Alzheimer's and other dementias. We have presented this evidence in the context of the evolution of public and professional awareness of dementia and its management and prescribing patterns over this time frame. We also briefly outline
Joanne, Rodda, Zuzana, Walker
openaire +2 more sources
Cholinesterase Inhibitors for Alzheimer's Disease
Hospital Practice, 1998New cholinesterase inhibitors capable of slowing the progression of Alzheimer's disease are being introduced at a rapid pace. In prescribing these drugs and setting realistic expectations for outcome, it is necessary to understand that they affect cholinergic activity in other tissues as well as the brain.
openaire +2 more sources
The next generation of cholinesterase inhibitors
Acta Neurologica Scandinavica, 2009Clinical trials with tacrine (THA) have resulted in elevations of liver enzymes in Alzheimer patients that showed improvement. In an effort to minimize these side effects several THA analogues were synthesized. These analogues were compared to THA in biochemical as well as behavioural studies.
openaire +2 more sources
Cholinesterases and Cholinesterase Inhibitors
Current Enzyme Inhibition, 2008Sarka Stepankova, Karel Komers
openaire +1 more source
Cholinesterase inhibitors for Alzheimer's disease
Cochrane Database of Systematic Reviews, 2006Since the introduction of the first cholinesterase inhibitor (ChEI) in 1997, most clinicians and probably most patients would consider the cholinergic drugs, donepezil, galantamine and rivastigmine, to be the first line pharmacotherapy for mild to moderate Alzheimer's disease.The drugs have slightly different pharmacological properties, but they all ...
openaire +2 more sources
Cholinesterase Inhibitors Stabilize Alzheimer's Disease
Annals of the New York Academy of Sciences, 2000Abstract: During the last decade, a systematic effort to develop a pharmacological treatment for Alzheimer disease (AD) has resulted into three drugs being registered for the first time in the USA and Europe for this specific indication. All three are cholinesterase inhibitors (ChEI).
openaire +5 more sources
Ocular Cholinesterase and Cholinesterase Inhibitors
American Journal of Ophthalmology, 1961openaire +2 more sources